Literature DB >> 3091296

Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma.

A E Smals, G F Pieters, A G Smals, T J Benraad, P W Kloppenborg.   

Abstract

An absent or severely blunted hGH response to an i.v. bolus injection (100 micrograms) of human pancreatic growth hormone releasing hormone (hpGRF 1-44) was found in seven female patients with Cushing's syndrome (five with pituitary dependent Cushing's disease and two due to an adrenal adenoma) and four men with pituitary dependent Cushing's disease. Three of the female and three of the male patients had an adequate hypoglycaemia after insulin administration. All these patients showed an absent or blunted hGH response after insulin induced hypoglycaemia. The GHRH data in these patients are in agreement with those in older literature on hGH responsiveness to stimuli such as L-dopa, arginine and insulin induced hypoglycaemia. It is concluded that hypercortisolism inhibits hGH release to various stimuli at the pituitary level.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091296     DOI: 10.1111/j.1365-2265.1986.tb01644.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men.

Authors:  R Rupprecht; A Niehaus; K P Lesch
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  The growth hormone response to growth hormone releasing hormone in patients previously treated with bilateral adrenalectomy alone for Cushing's disease.

Authors:  H M Whitehead; J A McKnight; B Sheridan; A L Kennedy; D R Hadden; A B Atkinson
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

Review 3.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

4.  Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.

Authors:  Silvia Regina Correa-Silva; Sérgio Oliva Nascif; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man.

Authors:  M H Borges; A C Pinto; F B DiNinno; C Camacho-Hübner; A Grossman; C E Kater; A M Lengyel
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

6.  Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.

Authors:  A M Lengyel; A L Toledo; M A Czepielewski; J G Vieira; A R Chacra
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

7.  GH secretion reserve in subclinical hypercortisolism.

Authors:  Serena Palmieri; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Elisa Cairoli; Volha V Zhukouskaya; Paolo Beck-Peccoz; Alfredo Scillitani; Iacopo Chiodini
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.